Sengenics Launches i-Ome Discovery™ to Advance Immune Biomarker Discovery
02 Oct 2023 //
BUSINESSWIRE
Sengenics Corporation Announces Yvonne Linney, PhD as New Board Director
09 Jan 2023 //
BUSINESSWIRE
Sengenics Broadens Its Systems Serology Tools to Enable the Detection
30 Nov 2022 //
BUSINESSWIRE
Sengenics Prepares for Next Phase Growth & Welcomes Bioscience Industry Leader
07 Sep 2022 //
BUSINESSWIRE
Sengenics Expands Autoantibody Biomarker Discovery Capability
22 Mar 2022 //
BUSINESSWIRE
Sengenics Launches AxCESS, a Research Services Suite to Enable Accessibility
02 Mar 2021 //
BUSINESSWIRE

Market Place
Sourcing Support